Navigation Links
FDA Accepts Genta's NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic Leukemia
Date:7/14/2008

Submission Based on Increased 5-Year Survival in Responding Patients

BERKELEY HEIGHTS, N.J., July 14 /PRNewswire-FirstCall/ -- Genta Incorporated (OTC Bulletin Board: GNTA) announced that the Food and Drug Administration (FDA) has accepted the Company's amendment to its New Drug Application (NDA) for Genasense(R) (oblimersen sodium) Injection as a "complete response". The NDA proposed the use of Genasense plus chemotherapy for patients with relapsed or refractory chronic lymphocytic leukemia (CLL). The recent submission was based on new information from the Company's completed, randomized Phase 3 trial that showed, among other findings, a significant increase in overall survival for patients who achieved a complete or partial response when treated with Genasense plus chemotherapy compared with patients treated with chemotherapy alone.

The amendment responds to a communication received in March 2008 from FDA's Center for Drug Evaluation and Research (CDER) that denied Genta's appeal of a prior "non-approvable" decision of the Genasense NDA in December 2006. That communication described a regulatory path forward that included but was not limited to determination of long-term survival in patients who entered the study. FDA has informed the Company that it considers Genta's complete response as a Class 2 resubmission with a Prescription Drug User Fee Act (PDUFA) goal date of December 3, 2008.

"We are pleased that the FDA will formally review this new information, and we look forward to working with FDA's Division of Oncology Drug Products during their consideration of this amendment," commented Dr. Loretta M. Itri, Genta's President, Pharmaceutical Development, and Chief Medical Officer.

About Chronic Lymphocytic Leukemia

CLL is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Partnering With MyPyramid: NUTRIKIDS Accepts the Challenge to Help Families Step Up to Healthier Living
2. AMEX Accepts Lorus Plan to Meet AMEXs Continued Listing Standards
3. Mike Huckabee Accepts Values Voter Presidential Debate
4. ev3 Inc. Accepts Resignation of Dr. John Simpson
5. Lieutenant Governor Catherine Baker Knoll Accepts Women in Government Presidential Leadership Award
6. FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
7. Governor Rendell Accepts National Health Care Reform Pioneer Award
8. American Stock Exchange Accepts Encisions Plan to Regain Compliance
9. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
10. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
11. Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Georgia (PRWEB) March 30, 2015 Innovaacom, ... healthcare professionals worldwide, today announced it is expanding its ... solutions for this area of the world comes at ... rallying around consumer demand for better healthcare. A rapidly ... healthcare system improvements and advances in medicine in Asia. ...
(Date:3/30/2015)... 2015 A key protein previously implicated ... an important role in the response to viral infection, ... Icahn School of Medicine at Mount Sinai published today ... been associated with inflammation, part of the body’s response ... home in to attack invaders like bacteria and viruses, ...
(Date:3/30/2015)... According to a recently published report ... market will continue to dominate the European soft tissue ... to increasing numbers of ventral hernias, and the adoption ... significantly large market share represented by ventral hernia repair ... seeing a growing use of expensive biologics,” explains Dr. ...
(Date:3/30/2015)... In a recent report published by ... is championing effective drug and alcohol treatment for victims ... recover funds to stabilize the addiction treatment programs, and ... drug and alcohol addiction. Harbor Village Detox is extending ... use disorders in New Jersey, in hopes to help ...
(Date:3/30/2015)... March 30, 2015 Vancouver personal injury ... the majority of cases taken up by the firm ... that the lawyers help protect the interests of their ... court process. The announcement comes across as an achievement ... is to provide convenience to their client, without compromising ...
Breaking Medicine News(10 mins):Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 3Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2
... beware. You may be more prone to an alcohol-induced ... from the Jefferson Headache Center. The research will be ... Society for Neuroscience, in Chicago. Until now, studying ... headaches has not been possible in an animal model, ...
... like norepinephrine, serotonin, and dopamine, are regulated a ... Current drugs for depression target the regulatory process for ... appear to work in other cases. Recent ... in the brain, are key players in the management ...
... the pain, experts say , SUNDAY, Oct. 18 (HealthDay News) -- ... it,s no surprise that children will try to flee, scream, cry ... year. , "The good news is that there are several ... when getting a needlestick -- whether it,s a flu shot, a ...
... CHICAGO Epileptic seizures are the most dramatic and ... when a person abruptly stops a long-term or chronic ... calcium ions into brain cells via voltage-gated calcium channels ... withdrawal seizures, because blocking this flow suppresses these seizures. ...
... disorder more likely to die within a year of ... News) -- Veterans with post-traumatic stress disorder face an ... surgery is performed years after they have completed their ... data on 1,792 male veterans who had major non-cardiac, ...
... BOCA RATON, Fla., Oct. 16 Certain cookie diets recently ... nutrition and having no apparent health benefits. Smart for Life ... it is a healthy lifestyle featuring products that are all-natural, ... Smart for Life is a healthy lifestyle that has become ...
Cached Medicine News:Health News:Migraine sufferers more prone to hangover headache 2Health News:Post-Traumatic Stress May Raise Death Risks 2Health News:Smart for Life(TM) Cookie Diet Provides Nutrients 2Health News:Smart for Life(TM) Cookie Diet Provides Nutrients 3
(Date:3/30/2015)... WILMINGTON, Del. , March 30, 2015  Rigrodsky & ... Auspex Pharmaceuticals, Inc. (NASDAQ GM: ASPX )? , ... 30, 2015? , Do you think the proposed buyout ... discuss your rights? Rigrodsky & Long, ... against the board of directors of Auspex Pharmaceuticals, Inc. ("Auspex" ...
(Date:3/30/2015)... DIEGO , March 30, 2015  Orexigen ... that Tom Cannell has joined as ... global commercialization of Contrave® /Mysimba™ (naltrexone HCl / ... aspects of Orexigen,s global commercial strategy, assuming responsibilities ... successfully leading Orexigen,s commercial effort through the U.S. ...
(Date:3/30/2015)... 30, 2015  New York College of Health Professions ... Properties portfolio with U.S. Patent #8,996,098 donated by its ... represents a surgical instrument that allows surgeons to view ... were in the traditional format of a slide that ... databases during surgery, thus providing the surgeon real time ...
Breaking Medicine Technology:AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10World Renowned Inventor Continues To Break Boundaries With Latest Patent 2World Renowned Inventor Continues To Break Boundaries With Latest Patent 3
... (Nasdaq: YDNT ) today announced that it will ... on-demand web cast conference call on Thursday, October 21, 2010 ... the call will be available through InterCall at http://tinyurl.com/Quarter32010 ... available through the Company,s website, www.ydnt.com . ...
... one of the world,s largest and most sophisticated pharmacies ... (D-Nev.), today said innovative companies such as Medco Health ... bright future for a sustainable healthcare system for America ... Nevada by providing employment opportunities for skilled healthcare professionals. ...
Cached Medicine Technology:Young Innovations, Inc. Provides 3rd Quarter Conference Call Details 2Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevada's Future 2Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevada's Future 3
... 2201 is ideal for applications such ... of heat. , ,The autoclavable handpiece ... of reusable thermal cautery electrodes, allowing ... to perform a wide variety of ...
Non-Cantilevered, "Teardrop" Ringed Forceps. ("fixation clamp") For vasectomy and other procedures. Ring ovoid approximately 6.0 mm in diameter....
... Stethoscope Module is an inconspicuous, lightweight, battery-operated instrument ... hear body functions amplified., ,The module controls ... switch, a tone switch, a stethoscope hearing aid ... switch will allow the user to select between ...
... ring receiver type earmold for ... of your ears are required. ... for the ear are distributed ... hearing healthcare providers. These providers ...
Medicine Products: